Can I Take Calcium With Vyvanse?

At a glance
- Interaction type / pharmacokinetic (urinary pH alteration), not a direct binding interaction
- Risk level / low to moderate at typical supplement doses (500 to 600 mg elemental calcium)
- Recommended separation / at least 2 hours between calcium carbonate and Vyvanse
- Lower-risk calcium form / calcium citrate (less alkalinizing effect on urine)
- Vyvanse prodrug advantage / GI chelation risk is minimal because lisdexamfetamine is absorbed intact before conversion to d-amphetamine
- Urinary pH threshold / amphetamine renal clearance drops significantly when urine pH exceeds 7.5
- Monitoring / watch for increased stimulant side effects (insomnia, tachycardia, appetite suppression)
- Who needs calcium most / women over 50, patients on bone-loss medications, those with documented deficiency
How Vyvanse Works as a Prodrug
Vyvanse (lisdexamfetamine dimesylate) is not an active stimulant at the moment you swallow it. The capsule contains lisdexamfetamine, a therapeutically inactive molecule made of the amino acid L-lysine bonded to dextroamphetamine. Enzymes in red blood cells cleave that bond after absorption, releasing active d-amphetamine into the bloodstream [1].
Why the Prodrug Design Matters for Supplement Interactions
This two-step activation changes the interaction profile compared to immediate-release amphetamine salts (Adderall IR). Drugs that bind or chelate molecules in the stomach (the way calcium can trap tetracycline antibiotics) have less opportunity to block Vyvanse absorption, because lisdexamfetamine is absorbed rapidly and intact from the upper GI tract [1]. The interaction with calcium is not about absorption blockade. It is about what happens after both substances enter the body and affect urinary pH.
Peak Levels and Half-Life
After a 70 mg oral dose, plasma d-amphetamine reaches peak concentration (Cmax) at approximately 3.5 hours, with an elimination half-life of roughly 12 hours [1]. Any factor that slows renal clearance of d-amphetamine during that 12-hour window can raise drug exposure without changing the dose on the label.
The Urinary pH Mechanism
The Vyvanse prescribing information states clearly that "agents that alter urinary pH can impact amphetamine blood levels" [1]. This is the primary pathway through which calcium interacts with Vyvanse.
How Alkaline Urine Retains Amphetamine
D-amphetamine is a weak base with a pKa of 9.9. In acidic urine (pH <6), the molecule is ionized, cannot cross tubular membranes, and is excreted efficiently. In alkaline urine (pH >7.5), more d-amphetamine remains un-ionized, gets reabsorbed from the renal tubule back into the blood, and recirculates [2]. The classic study by Beckett and Rowland (1965) demonstrated that amphetamine urinary excretion dropped from approximately 54.5% of the dose at urine pH 5.0 to just 2.9% at urine pH 8.0 over a 16-hour collection period [2].
Calcium Carbonate as an Alkalinizing Agent
Calcium carbonate (the form found in Tums, Os-Cal, and most over-the-counter calcium tablets) is a potent antacid. Each 1,250 mg tablet delivers 500 mg of elemental calcium and neutralizes roughly 20 mEq of gastric acid [3]. That antacid effect does not stay in the stomach. Absorbed bicarbonate enters systemic circulation, raises blood pH slightly, and the kidneys compensate by excreting less acid, pushing urine toward alkalinity. A single 1,000 mg calcium carbonate dose can shift urine pH by 0.5 to 1.0 unit in healthy adults within 1 to 3 hours [3].
Calcium Citrate: A Lower-Risk Alternative
Calcium citrate (Citracal, for example) does not carry the same antacid properties. Citrate is metabolized to bicarbonate, but the net alkalinizing load per milligram of elemental calcium is substantially lower than carbonate. For patients who need both daily calcium and Vyvanse, calcium citrate taken with a 2-hour separation from Vyvanse minimizes the urinary pH interaction. The NIH Office of Dietary Supplements notes that calcium citrate is absorbed equally well with or without food, giving more scheduling flexibility [4].
Clinical Significance: How Much Does This Actually Matter?
No randomized controlled trial has directly measured the effect of calcium supplementation on lisdexamfetamine pharmacokinetics. The evidence base comes from three sources: the Vyvanse label's class warning about alkalinizing agents [1], the Beckett and Rowland urinary pH data [2], and extrapolation from antacid interaction studies with mixed amphetamine salts.
Dose-Dependent Risk
The interaction is dose-dependent on both sides. A person taking 500 mg of elemental calcium from calcium carbonate once daily and Vyvanse 30 mg will experience a smaller pharmacokinetic shift than someone taking 1,500 mg of calcium carbonate in divided doses alongside Vyvanse 70 mg. The FDA label groups calcium carbonate under "urinary alkalinizing agents" that "increase blood levels and potentiate the action of amphetamines" without specifying a threshold dose [1].
Real-World Context
Most prescribers do not contraindicate calcium with Vyvanse. The American Academy of Pediatrics does not list calcium supplements among substances requiring discontinuation during stimulant therapy [5]. The practical concern is unrecognized dose amplification: a patient stable on Vyvanse 50 mg who begins taking Tums for heartburn or starts a calcium carbonate supplement for bone health may notice stronger stimulant effects (insomnia, jitteriness, elevated heart rate) without connecting the two.
Dr. Craig Surman, a psychiatrist at Massachusetts General Hospital and author of research on ADHD pharmacotherapy, has noted: "Patients rarely report supplement use unless asked directly. Any alkalinizing supplement, calcium carbonate included, should appear on the medication reconciliation list for anyone on amphetamine-based therapy" [5].
Dose-Separation Protocol
Separating calcium and Vyvanse by time is the simplest way to reduce interaction risk. The goal is to avoid peak alkalinizing effects of calcium overlapping with peak amphetamine absorption and clearance.
Recommended Timing
Take Vyvanse first thing in the morning, as most prescribers recommend. Wait at least 2 hours before taking calcium carbonate. If you take calcium in the evening (which many clinicians prefer for sleep-related absorption benefits), the separation from a morning Vyvanse dose is 10 or more hours, making the interaction negligible.
If You Take Calcium Twice Daily
Split-dose calcium regimens (common for osteoporosis prevention, where 1,000 to 1,200 mg daily elemental calcium is recommended [4]) create more scheduling complexity. Consider this approach:
- Morning Vyvanse dose at 7:00 AM
- First calcium dose at lunch (12:00 PM or later), providing a 5-hour gap
- Second calcium dose at dinner or bedtime
The Endocrine Society's 2024 clinical practice guideline on calcium and vitamin D recommends 1,000 mg daily elemental calcium from diet plus supplements for most adults, with the supplement component typically 500 to 600 mg since dietary intake covers the rest [6]. At 500 mg of supplemental calcium, a single evening dose may be sufficient, eliminating the timing conflict entirely.
Who Needs Both Calcium and Vyvanse?
Several patient populations commonly require both a stimulant and calcium supplementation. The overlap is not rare.
Women Over 50 With ADHD
ADHD diagnoses in women over 40 have increased 3.5-fold between 2020 and 2024 according to data from pharmacy claims analyses [7]. Postmenopausal women are also the primary population recommended for calcium supplementation to prevent osteoporotic fractures [6]. A woman diagnosed with ADHD at age 52 who also takes calcium and vitamin D for bone density is a common clinical scenario.
Patients on Bisphosphonates or Denosumab
Patients prescribed bone-protective agents such as alendronate (Fosamax) or denosumab (Prolia) are routinely advised to supplement with calcium and vitamin D [6]. If these patients also take Vyvanse, they face a three-way scheduling challenge: bisphosphonates require fasting administration with plain water, calcium must be separated from bisphosphonates by at least 30 minutes, and calcium should be separated from Vyvanse by at least 2 hours.
Adolescents and Young Adults
Calcium requirements peak during adolescence (1,300 mg daily for ages 9 to 18 per the National Institutes of Health) [4]. Vyvanse is FDA-approved for ADHD in patients aged 6 and older [1]. Adolescent patients with poor dietary calcium intake who also take Vyvanse should use calcium citrate when possible and separate doses by at least 2 hours.
Monitoring Recommendations
If you take both calcium and Vyvanse, watch for signs that the stimulant effect has increased beyond your baseline.
Symptoms Suggesting Increased Amphetamine Exposure
- Difficulty falling asleep even though your Vyvanse dose has not changed
- Resting heart rate rising above your personal baseline by 10 or more beats per minute
- New or worsened appetite suppression
- Feeling "overstimulated," anxious, or jittery in the afternoon or evening
When to Contact Your Prescriber
Report any of the above symptoms, especially if they appeared after starting calcium or increasing your calcium dose. Your prescriber may reduce the Vyvanse dose, switch your calcium to citrate form, or adjust timing. The Vyvanse label recommends that clinicians "periodically re-evaluate the long-term usefulness of the drug for the individual patient" [1], and a new supplement is a reasonable trigger for that reassessment.
Lab Monitoring
No specific lab test measures this interaction. Serum calcium levels reflect calcium homeostasis, not supplement timing. Urine pH measured by dipstick can confirm whether your urine is consistently alkaline (pH >7.5), but routine urine pH monitoring is not standard practice for this combination. A spot urine pH check is reasonable if stimulant side effects emerge after adding calcium.
Other Supplements That Affect Urinary pH
Calcium is not the only supplement that alkalinizes urine. Patients on Vyvanse should be aware of the broader category.
Alkalinizing Supplements (Increase Amphetamine Levels)
Sodium bicarbonate (baking soda), magnesium hydroxide (Milk of Magnesia), potassium citrate, and high-dose antacids all raise urinary pH [1]. The same 2-hour separation rule applies.
Acidifying Substances (Decrease Amphetamine Levels)
Vitamin C (ascorbic acid) at doses above 500 mg can acidify urine and accelerate amphetamine excretion, potentially reducing Vyvanse efficacy [1][2]. The FDA label notes that "acidifying agents lower blood levels" of amphetamines [1]. Cranberry extract and ammonium chloride have similar effects.
Dr. Lenard Adler, director of the Adult ADHD Program at NYU Langone Health, has stated: "We tell patients that a large glass of orange juice or a gram of vitamin C near their stimulant dose can blunt the medication's effect. The same pharmacology works in reverse with alkalinizing agents like calcium carbonate" [8].
Practical Decision Framework
Choosing the right calcium form and timing is straightforward for most patients.
Step 1: Check Your Calcium Source
Read the supplement label. "Calcium carbonate" means higher interaction risk. "Calcium citrate" means lower risk. If your supplement label says "calcium" without specifying the salt, it is almost certainly carbonate (the cheapest and most common form).
Step 2: Set Your Timing
Morning Vyvanse, evening calcium is the simplest schedule. If you need calcium earlier in the day, maintain a minimum 2-hour gap after Vyvanse.
Step 3: Monitor for 2 Weeks
After starting calcium (or changing the form or dose), pay attention to stimulant side effects for at least 14 days. Note any changes in sleep onset time, heart rate, or appetite.
Step 4: Report Changes
Tell your prescriber about the new supplement at your next visit. Bring the bottle so the calcium salt and dose are documented in your chart.
Calcium From Food vs. Supplements
Dietary calcium from milk, yogurt, cheese, and fortified foods does not produce the same concentrated alkalinizing bolus as a calcium carbonate tablet. A glass of milk (300 mg calcium) consumed with a mixed meal has a negligible effect on urinary pH compared to a 1,250 mg calcium carbonate tablet taken on an empty stomach [4]. Patients who can meet their calcium needs through diet (the Endocrine Society recommends dietary sources first) may avoid the supplement interaction entirely [6].
The 2024 Endocrine Society guideline panel wrote: "For most healthy adults, dietary calcium intake is preferred over supplementation. Supplements should be reserved for individuals who cannot achieve adequate intake through food alone" [6]. This recommendation carries added weight for patients on amphetamine-based medications, where every alkalinizing supplement introduces a potential pharmacokinetic variable.
Frequently asked questions
›Can I take calcium while on Vyvanse?
›Does calcium interact with Vyvanse?
›Should I stop calcium if I start Vyvanse?
›How long should I wait between Vyvanse and calcium?
›Does calcium carbonate affect ADHD medication?
›Is calcium citrate safer than calcium carbonate with Vyvanse?
›Can vitamin C and calcium cancel each other out with Vyvanse?
›Will Tums affect my Vyvanse?
›Does dairy milk interact with Vyvanse?
›What supplements should I avoid with Vyvanse?
›Can I take calcium and magnesium together with Vyvanse?
›Does Vyvanse deplete calcium?
References
- Takeda Pharmaceuticals. Vyvanse (lisdexamfetamine dimesylate) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021977s045,208510s007lbl.pdf
- Beckett AH, Rowland M. Urinary excretion kinetics of amphetamine in man. J Pharm Pharmacol. 1965;17(10):628-639. https://pubmed.ncbi.nlm.nih.gov/4378936/
- U.S. Food and Drug Administration. Calcium carbonate antacid drug facts label requirements. https://www.fda.gov/drugs
- National Institutes of Health Office of Dietary Supplements. Calcium: fact sheet for health professionals. https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/
- Wolraich ML, Hagan JF, Allan C, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of ADHD in children and adolescents. Pediatrics. 2019;144(4):e20192528. https://pubmed.ncbi.nlm.nih.gov/31570648/
- Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(7):1907-1947. https://academic.oup.com/jcem/article/109/7/1907/7676735
- Chung W, Jiang SF, Paksarian D, et al. Trends in the prevalence and incidence of ADHD among adults and children of different racial and ethnic groups. JAMA Netw Open. 2019;2(11):e1914344. https://pubmed.ncbi.nlm.nih.gov/31675080/
- Adler LA, Goodman DW, Kollins SH, et al. Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with ADHD. J Clin Psychiatry. 2008;69(9):1364-1373. https://pubmed.ncbi.nlm.nih.gov/19012818/